Hecker L I, Elespuru R K, Farrelly J G
Mutat Res. 1979 Sep;62(2):213-20. doi: 10.1016/0027-5107(79)90079-4.
Various cell fractions from rat liver were tested for their ability to convert nitrosopyrrolidine (NO-PYR) to products which were mutagenic to E. coli in liquid-incubation assays. Microsomes alone produced only a small number of tyr+ revertants, approximately 40/10(8) survivors), while the S100 supernatant produced none at all. However, the S8 Fraction or combinations of microsomes and the S100 supernatant, yielded 300-400 tyr+ revertants/10(8) survivors. Neither products of the microsomal, nor microsome + supernatant reactions were mutagenic in the absence or presence of cellular fractions. These results suggest that bacterial mutagens are formed during the microsomal metabolism of NO-PYR to 2-hydroxytetrahydrofuran by alpha-hydroxylation, but not during the metabolism of 2-hydroxytetrahydrofuran by the S100 supernatant enzymes. Possible roles of the supernatant enzymes in the formation of mutagenic intermediates during the initial alpha-hydroxylation of NO-PYR are discussed.
在液体培养试验中,对来自大鼠肝脏的各种细胞组分转化亚硝基吡咯烷(NO-PYR)为对大肠杆菌具有致突变性产物的能力进行了测试。仅微粒体产生少量的tyr+回复突变体(约40/10⁸存活菌),而S100上清液根本不产生。然而,S8组分或微粒体与S100上清液的组合产生300 - 400个tyr+回复突变体/10⁸存活菌。微粒体反应产物以及微粒体 + 上清液反应产物在不存在或存在细胞组分的情况下均无致突变性。这些结果表明,细菌诱变剂是在微粒体将NO-PYR通过α-羟基化代谢为2-羟基四氢呋喃的过程中形成的,而不是在S100上清液酶将2-羟基四氢呋喃代谢的过程中形成。讨论了上清液酶在NO-PYR初始α-羟基化过程中诱变中间体形成中的可能作用。